Mutual of America Capital Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.96M Sell
59,391
-1,348
-2% -$44.5K 0.02% 823
2025
Q1
$2.44M Sell
60,739
-1,600
-3% -$64.3K 0.03% 747
2024
Q4
$2.93M Sell
62,339
-1,248
-2% -$58.7K 0.03% 713
2024
Q3
$3.36M Sell
63,587
-2,058
-3% -$109K 0.04% 669
2024
Q2
$3.56M Buy
65,645
+7,208
+12% +$391K 0.04% 627
2024
Q1
$4.1M Buy
58,437
+41,275
+241% +$2.89M 0.04% 581
2023
Q4
$1.43M Buy
17,162
+337
+2% +$28.1K 0.02% 994
2023
Q3
$496K Sell
16,825
-1,856
-10% -$54.7K 0.01% 1122
2023
Q2
$609K Sell
18,681
-806
-4% -$26.3K 0.01% 1096
2023
Q1
$686K Sell
19,487
-345
-2% -$12.1K 0.01% 1072
2022
Q4
$909K Buy
19,832
+1,103
+6% +$50.5K 0.01% 1042
2022
Q3
$907K Buy
18,729
+4,344
+30% +$210K 0.01% 1040
2022
Q2
$565K Buy
14,385
+2,298
+19% +$90.3K 0.01% 1081
2022
Q1
$445K Buy
12,087
+627
+5% +$23.1K ﹤0.01% 1136
2021
Q4
$522K Buy
11,460
+323
+3% +$14.7K 0.01% 1111
2021
Q3
$398K Buy
11,137
+939
+9% +$33.6K ﹤0.01% 1161
2021
Q2
$202K Buy
10,198
+701
+7% +$13.9K ﹤0.01% 1383
2021
Q1
$221K Buy
9,497
+649
+7% +$15.1K ﹤0.01% 1335
2020
Q4
$184K Buy
8,848
+340
+4% +$7.07K ﹤0.01% 1311
2020
Q3
$184K Buy
8,508
+5,595
+192% +$121K ﹤0.01% 1251
2020
Q2
$69K Buy
2,913
+346
+13% +$8.2K ﹤0.01% 1265
2020
Q1
$30K Buy
2,567
+511
+25% +$5.97K ﹤0.01% 1402
2019
Q4
$22K Sell
2,056
-124
-6% -$1.33K ﹤0.01% 1544
2019
Q3
$25K Buy
2,180
+103
+5% +$1.18K ﹤0.01% 1521
2019
Q2
$23K Buy
2,077
+512
+33% +$5.67K ﹤0.01% 1535
2019
Q1
$13K Buy
1,565
+195
+14% +$1.62K ﹤0.01% 1605
2018
Q4
$9K Buy
1,370
+322
+31% +$2.12K ﹤0.01% 1623
2018
Q3
$10K Buy
1,048
+861
+460% +$8.22K ﹤0.01% 1619
2018
Q2
$2K Buy
+187
New +$2K ﹤0.01% 1597